罕见病知识库 RareSeen

肝豆状核变性

Wilson disease

定义 英文原文(暂无中文)

A rare genetic disorder of copper metabolism presenting with non-specific hepatic, neurologic, psychiatric or ophthalmologic manifestations due to impaired biliary copper excretion and consecutive excessive copper deposition in the body.

别名

肝豆状核变性

基本事实

遗传方式
常染色体隐性
发病年龄
青少年期、成年期、儿童期、老年期
患病率
1-9 / 100 000

相关基因 1

基因名称关联类型
ATP7BATPase copper transporting betaDisease-causing germline mutation(s) (loss of function) in

临床表型 57

极常见 99–80%33

  • 手异常 HP:0001155
  • 月经周期异常 HP:0000140
  • 急性肝功能衰竭 HP:0006554
  • 急性肝炎 HP:0200119
  • 攻击性行为 HP:0000718
  • 性行为增多 HP:5200321
  • 贫血 HP:0001903
  • 关节疼痛 HP:0002829
  • 关节炎 HP:0001369
  • 背部疼痛 HP:0003418
  • 骨痛 HP:0002653
  • 瘀斑易感性 HP:0000978
  • 肝硬化 HP:0001394
  • 笨拙 HP:0002312
  • 抑郁 HP:0000716
  • 构音障碍 HP:0001260
  • 循环肝转氨酶水平升高 HP:0002910
  • 发育迟滞 HP:0001508
  • 步态异常 HP:0001288
  • 肝脂肪变性 HP:0001397
  • 肝炎 HP:0012115
  • 肝脏肿大 HP:0002240
  • 体重增加 HP:0004324
  • 智力障碍 HP:0001249
  • 黄疸 HP:0000952
  • 关节肿胀 HP:0001386
  • 角膜色素环 HP:0200032
  • 病理性骨折 HP:0002756
  • 下肢近端肌无力 HP:0008994
  • 瘙痒 HP:0000989
  • 脾肿大 HP:0001744
  • 血小板减少症 HP:0001873
  • 体重减轻 HP:0001824

常见 79–30%8

  • 舞蹈样运动 HP:0002072
  • 血清铜蓝蛋白降低 HP:0010837
  • 肌张力障碍 HP:0001332
  • 步态异常 HP:0001288
  • 溶血性贫血 HP:0001878
  • 骨质疏松 HP:0000939
  • 性格改变 HP:0000751
  • 震颤 HP:0001337

偶见 29–5%15

  • 腹痛 HP:0002027
  • 氨基酸尿 HP:0003355
  • 焦虑 HP:0000739
  • 腹水 HP:0001541
  • 唾液分泌过多 HP:0003781
  • 脑干局灶性T2高信号病变 HP:0012748
  • 幻觉 HP:0000738
  • 甲状旁腺功能减退症 HP:0000829
  • 不孕症/不育症 HP:0000789
  • 失眠 HP:0100785
  • 肾结石 HP:0000787
  • 胰腺炎 HP:0001733
  • 精神病 HP:0000709
  • 癫痫发作 HP:0001250
  • 呕吐 HP:0002013

罕见 <4–1%1

  • 向日葵样白内障 HP:6000642

近两年的全球研究 1,834L2

2024/10 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。

  • 2026-11开放获取
    Essential Oral Single Nutritional Therapy Products for Inherited Metabolic Diseases: Evidence and Consensus Assessment Using a Modified Delphi Method
    Journal of inherited metabolic disease · DOI · Europe PMC
  • 2026-10
    Correction: CRISPR/Cas9-mediated gene correction of Wilson disease H1069Q point mutation in patient-specific induced pluripotent stem cells
    Gene therapy · DOI · Europe PMC
  • 2026-10
    Genome-wide transcriptomics and a machine learning-based random forest model identify novel biomarkers to predict phenotypic variability in Wilson disease
    Human immunology · DOI · Europe PMC
  • 2026-10
    Eriocitrin Attenuates Diabetic Cardiomyopathy by Regulating Copper Homeostasis and Cuproptosis-Associated Pathways via SIRT7/YAP/ATP7A Signalling
    Basic & clinical pharmacology & toxicology · DOI · Europe PMC
  • 2026-10
    Analysis of end-stage renal disease mediated by cuproptosis-related genes
    Clinical nephrology · 被引 1 · DOI · Europe PMC
  • 2026-09开放获取
    Restoring brain functions in the Mo-blo mouse model of Menkes disease with copper nanoclusters
    Science advances · DOI · Europe PMC
  • 2026-09开放获取
    Bio-Memristor Based on Clinical Bile Samples: A Proof-of-Concept Pilot Study for Detection of Gallbladder Cancer
    Advanced science (Weinheim, Baden-Wurttemberg, Germany) · DOI · Europe PMC
  • 2026-09开放获取
    Copper-Driven Epithelial Barrier Disruption: A Novel Mechanism of COPD Acute Exacerbations Mediated by the TNF-α/ATP7A Axis
    Advanced science (Weinheim, Baden-Wurttemberg, Germany) · DOI · Europe PMC
  • 2026-09
    Disrupted copper homeostasis promotes osteopontin-mediated hepatocyte-stellate cell crosstalk in Wilson disease
    Cytokine · DOI · Europe PMC
  • 2026-09综述开放获取
    Cuproptosis and ferroptosis: signal pathways, diseases and therapeutic targets
    Signal transduction and targeted therapy · DOI · Europe PMC
  • 2026-09
    digitalMLPA EZtec-MS: A new highly multiplexed DNA probe-based technique for neonatal screening
    European journal of human genetics : EJHG · DOI · Europe PMC
  • 2026-09病例报告开放获取
    Fragile X-associated tremor/ataxia syndrome with autoimmune hepatitis requiring liver transplantation
    BMJ case reports · DOI · Europe PMC
  • 2026-09开放获取
    Neutrophil extracellular traps delivering lactylated S100a9 aggravate neuronal cuproptosis by regulating Ttr/Commd1/Atp7b axis after traumatic brain injury
    Redox biology · DOI · Europe PMC
  • 2026-09开放获取
    Effects of Dietary Copper on Growth Performance, Antioxidant Capacity, Muscle Quality and the Expression of Copper-Transport and Muscle Development-Related Genes in Juvenile Red Swamp Crayfish (&lt;i&gt;Procambarus clarkii&lt;/i&gt;)
    Animals : an open access journal from MDPI · DOI · Europe PMC
  • 2026-09开放获取
    Genetic testing and exchangeable copper can improve the accuracy of Wilson disease diagnoses
    Hepatology communications · DOI · Europe PMC
  • 2026-09开放获取
    The Childhood Liver Disease Research Network's prospective characterization of pediatric primary sclerosing cholangitis
    Hepatology communications · DOI · Europe PMC
  • 2026-09
    Functional analysis of the methanobactin-encoding gene cluster of &lt;i&gt;Methylocystis&lt;/i&gt; sp. strain SB2
    Microbiology spectrum · DOI · Europe PMC
  • 2026-09开放获取
    SOX2 Inhibits Cuproptosis to Affect Cisplatin Resistance in Non-Small Cell Lung Cancer by Activating the Wnt/ATP7B Signaling Pathway
    The Kaohsiung journal of medical sciences · DOI · Europe PMC
  • 2026-09
    Therapeutic Management of Wilson Disease in Clinical Practice: Multicenter Retrospective Real-World Data from Germany
    Zeitschrift fur Gastroenterologie · DOI · Europe PMC
  • 2026-09荟萃分析开放获取
    Conserved hepatic RNA signatures across multiple cohorts reveal novel mechanistic clues for advanced fibrosis in human MASLD
    Hepatology communications · DOI · Europe PMC

境外已获批用于本病的药物 3L2

欧盟 3 项、美国 0 项。同一药物在两地各批一次的,会分别列出。

「境外已获批」不等于「在中国能用」。中间隔着进口注册、临床急需境外新药通道、海南博鳌乐城国际医疗旅游先行区等几条路径,各有各的条件与费用。这一节能确定地告诉你的只有一件事:这个病在世界范围内已经有获得批准的药物,它叫什么名字。拿这个名字去问主治医生,是下一步最省力的做法。

药名一律保留英文原文,不作翻译——中国的药品通用名与英文名的音译经常不一致,译错会让人去找一个不存在的药。

尚未获批的在研药物(2 项)

这些药已被欧盟或美国的监管机构认定为罕见病用药(英文 orphan drug designation,中文行业里通称「孤儿药资格」——「孤儿」说的是这类药市场太小、没有厂商愿意认领,不是在说病人)。但这只是一种监管身份:意味着监管机构给予研发上的激励,不代表这个药已被证明有效,也不代表将来一定能上市,绝大多数最终不会成药。列在这里是为了看清有哪些方向正在被尝试。

  • methanobactin SB2美国2024-08-06
    treatment of Wilson Disease
    官方记录
  • recombinant adeno-associated viral vector of serotype 8 carrying the c美国2024-08-06
    treatment of Wilson Disease
    官方记录

数据来自欧洲药品管理局(EMA)的药品与罕见病用药资格公开导出表,以及美国 FDA 的罕见病用药资格数据库(Orphan Drug Product Designation Database)。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。

在中国开展的临床试验 16L2

按病名在 ClinicalTrials.gov 检索、并校验研究中心含中国大陆而来。登记状态不等于现在真的能入组——务必按 NCT 号到原站核实,并与主治医生商量。

登记为可入组 10

  • 招募中NCT04965558
    Clinical Features and Outcome in Patients With Osseomuscular Type of Wilson's Disease
    观察性 · 2004/01/01Second Affiliated Hospital, Zhejiang University, School of Medicine
    中国研究中心 1 个:Hangzhou
  • 招募中NCT04965545
    Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease
    观察性 · 2004/01/01Second Affiliated Hospital, Zhejiang University, School of Medicine
    中国研究中心 1 个:Hangzhou
  • 招募中NCT03131427
    China Registry for Genetic / Metabolic Liver Diseases
    观察性 · 2015/06/13Beijing Friendship Hospital
    中国研究中心 12 个:Beijing、Chengdu、Guangzhou、Shanghai、Shijiazhuang、Tianjin 等 8 地
  • 招募中NCT04012658
    A Registered Cohort Study on Wilson's Disease
    观察性 · 2019/07/01Wan-Jin Chen
    中国研究中心 1 个:Fuzhou
  • 尚未开始招募NCT06196931
    Clinical Value of DWI-ADC Matching in the Short-term Prognosis of Wilson's Disease
    观察性 · 2024/01/01Hospital Affiliated to the Institute of Neurology, Anhui University of Chinese Medicine
    中国研究中心 1 个:Hefei
  • 招募中NCT06650319
    A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease
    早期 I 期 · 干预性 · 2024/09/24Chaohui Yu
    中国研究中心 1 个:Hangzhou
  • 尚未开始招募NCT07173933
    Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD)
    I 期、II 期 · 干预性 · 2025/10GeneCradle Inc
    中国研究中心 1 个:Beijing
  • 招募中NCT07240896
    A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)
    早期 I 期 · 干预性 · 2025/12/31DSciLab Co., Ltd.
    中国研究中心 1 个:Hefei
  • 尚未开始招募NCT07641140
    Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease
    I 期、II 期 · 干预性 · 2026/06/15Lingyi Biotech Co., Ltd.
    中国研究中心 1 个:Hangzhou
  • 尚未开始招募NCT07465718
    Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.
    III 期 · 干预性 · 2026/08Orphalan
    中国研究中心 3 个:Beijing、Hangzhou
其他状态的试验(6 项)
  • 已完成NCT04965571
    Clinical Features and Outcome of Wilson's Disease With Generalized Epilepsy in Chinese Patients
    观察性 · 2010/09/01Second Affiliated Hospital, Zhejiang University, School of Medicine
    中国研究中心 1 个:Hangzhou
  • 已完成NCT06762509
    The Clinical Study of Botulinum Toxin Type A Injection in the Treatment of Wilson Disease
    观察性 · 2016/12/01The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
    中国研究中心 1 个:Hefei
  • 状态未知NCT03589820
    Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease-related Liver Failure
    不适用 · 干预性 · 2018/06/01Third Affiliated Hospital, Sun Yat-Sen University
    中国研究中心 1 个:Guangzhou
  • 状态未知NCT03957720
    The Individual Therapy for Patients With Wilson's Disease
    早期 I 期 · 干预性 · 2019/03/15Second Affiliated Hospital, Zhejiang University, School of Medicine
    中国研究中心 1 个:Hangzhou
  • 状态未知NCT05305872
    Gandouling in the Treatment of Wilson's Disease
    IV 期 · 干预性 · 2023/01/01Jun Li
    中国研究中心 1 个:Hefei
  • 进行中·不再招募NCT06663878
    An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease
    不适用 · 干预性 · 2024/10/28Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
    中国研究中心 1 个:Shanghai

中国境外的在招试验 29L2

这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。

法国8美国3意大利2德国2西班牙2英国2新西兰1印度1阿根廷1比利时1波兰1沙特阿拉伯1

CT.gov 报告命中 29 项,此处取回并展示最近的 15 项。

  • 招募中NCT07748403
    A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)
    I 期、II 期 · 干预性 · 2026/09Prime Medicine, Inc.
    新西兰、美国
  • 尚未开始招募NCT07208565
    Endocrine Dysfunction in Pediatric Wilson's Disease
    观察性 · 2026/06/30Assiut University
  • 尚未开始招募NCT07476417
    Oral Health, Dento-facial Condition and OHRQoL in Subjects With Mowat-Wilson Syndrome: an Epidemiologic Study.
    观察性 · 2026/04/01University of Milan
    意大利
  • 尚未开始招募NCT07075393
    Description of Renal Involvement in Wilson's Disease
    观察性 · 2026/02Fondation Ophtalmologique Adolphe de Rothschild
    法国
  • 招募中NCT07301216
    Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot Study
    观察性 · 2026/01/08Yale University
    美国
  • 尚未开始招募NCT07241832
    Multifaceted Assessment of Patients With Wilson's Disease in a Low-Resource Setting in Upper Egypt: Service Integration, Psychosocial Burden, Dietary Practices, and the Geo-Spatial Disease Map
    观察性 · 2025/12/01Assiut University
  • 招募中NCT06945081
    Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity
    不适用 · 干预性 · 2025/11/28Centre Hospitalier Universitaire de Saint Etienne
    法国
  • 招募中NCT06430359
    Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients
    观察性 · 2025/01/10Hospices Civils de Lyon
    法国
  • 尚未开始招募NCT06698991
    Daily Versus Alternate Day Plasma Exchange in Wilson Disease With Acute Liver Failure in Children
    不适用 · 干预性 · 2024/11/10Institute of Liver and Biliary Sciences, India
    印度
  • 招募中NCT06573723
    Institutional Registry of Rare Diseases
    观察性 · 2024/07/01Hospital Italiano de Buenos Aires
    阿根廷
  • 尚未开始招募NCT06051734
    Early Detection of Cardiac Affection in Patients of Wilson's Disease
    观察性 · 2023/10/01Assiut University
  • 招募中NCT05444127
    Oral Health and Wilson's Disease: SOMAWI
    观察性 · 2023/05/17Fondation Ophtalmologique Adolphe de Rothschild
    法国
  • 招募中NCT05493605
    Cardiac Involvement in Wilson's Disease
    不适用 · 干预性 · 2023/03/02Fondation Ophtalmologique Adolphe de Rothschild
    法国
  • 招募中NCT05239858
    International Wilson's Disease Patient Registry (iWilson Registry)
    观察性 · 2022/06/29Orphalan
    比利时、法国、德国、波兰、沙特阿拉伯、西班牙、英国
  • 招募中NCT05183165
    Description of the Copper Concentration in Breast Milk in Women Treated for Wilson's Disease
    不适用 · 干预性 · 2022/05/11Fondation Ophtalmologique Adolphe de Rothschild
    法国

外部标识与链接

发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号

本页数据来源

  • 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
  • 中文病名:Orphanet 中文包,冻结于 2020-06-01
  • 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)